Roth/MKM Starts Dianthus Therapeutics (DNTH) at Buy

October 26, 2026 4:08 PM EDT Send to a Friend
Roth/MKM analyst Adam Walsh initiates coverage on Dianthus Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login